Tirzepatide has not been compared directly with other weight-loss medications
For a substance or method to be added to the List, it must be determined that it meets at least two of the following three criteria: 1
Users describe being charged early, double-charged, or charged for medication they never received
Our prior authorization article covers this in more detail: Medicare Prior Authorization Changes in Washington 2026
In this guide, we will break down the battle of Tirzepatide vs Ozempic vs Victoza
After reviewing clinical trial data, post-marketing surveillance reports, and real-world evidence across millions of prescriptions, the EMA concluded in 2024 that the available evidence does not support a causal association between GLP1 receptor agonists and suicidal or self-injurious behavior